Myokardia Inc (MYOK)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
224.91 +0.11 (+0.05%) 11/16/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 224.91 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,436 | 246,122 | 224,571 | 135,797 | 112,265 |
| Marketable Securities | 314,691 | 68,564 | 31,933 | 4,072 | N/A |
| Receivables | N/A | N/A | 1,013 | 45,000 | N/A |
| TOTAL | $423,836 | $319,446 | $259,393 | $186,263 | $113,547 |
| Non-Current Assets | |||||
| PPE Net | 15,743 | 5,138 | 3,147 | 2,758 | 2,744 |
| Investments And Advances | 14,153 | 80,148 | 19,900 | 12,002 | 0 |
| Other Non-Current Assets | 2,362 | 2,521 | 368 | 283 | 289 |
| TOTAL | $32,258 | $87,807 | $23,415 | $15,043 | $3,033 |
| Total Assets | $456,094 | $407,253 | $282,808 | $201,306 | $116,580 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,237 | 2,946 | 2,301 | 1,798 | 2,143 |
| Accrued Expenses | 41,292 | 20,758 | 11,639 | 8,690 | 5,633 |
| Other current liabilities | N/A | 12,973 | 4,432 | N/A | N/A |
| TOTAL | $47,912 | $36,677 | $51,930 | $32,988 | $21,975 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 33,558 | 22,500 | 14,199 |
| aiOther Non-Current Liabilities | 1,908 | 9 | 202 | 436 | 732 |
| TOTAL | $1,908 | $9 | $202 | $22,936 | $732 |
| Total Liabilities | $49,820 | $36,686 | $52,132 | $55,924 | $22,707 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,575 | 40,320 | 35,924 | 31,417 | 27,016 |
| Common Shares | 5 | 4 | 4 | 3 | 3 |
| Retained earnings | -478,766 | -202,553 | -134,855 | -77,837 | -64,685 |
| Other shareholders' equity | 549 | -67 | -192 | 8 | 0 |
| TOTAL | $406,274 | $370,567 | $230,676 | $145,382 | $93,873 |
| Total Liabilities And Equity | $456,094 | $407,253 | $282,808 | $201,306 | $116,580 |